Skip to main content

Table 1 Patient characteristics

From: First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9

Patient

Age (years)

BMI (kg/m2)

Gleason score

PSA (ng/ml)

PSA doubling time (months)

68Ga-MJ9 PET/CT findings

1

62

31.4

9

8.5

2

Lymph nodes + bone metastases

2a

68

22.1

7

2.3

1

Bone metastases

3b

67

27.5

6

3.4

18

Bone metastases

4b

72

24.9

9

7.7

4.4

Lymph-nodal metastases

5

56

24.3

8

7.3

12

Local relapse

  1. aHistory of pancreatic carcinoma treated with pancreaticoduodenectomy, and adjuvant chemo- and radiotherapy
  2. bHistory of gallstones treated with cholecystectomy